Regulatory information – adjusted fees for applications to EMA from 1 April 2018

March 5, 2018 – The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on 1 April 2018. Every year, the European CommissionExternal link icon adopts a regulation adjusting the fees payable to the Agency with reference to the inflation rate in the European Union for the previous year. The 2017 inflation rate was 1.7% … (leggi tutto)